EDQM: Policy for CEP Applications published for Comments

Recommendation
Wednesday, 21 May 2025 10.00 - 16.00 h
How to use and prepare an MA with a CEP 2.0
In June, the draft Certification Policy Document PA/PH/CEP(04) 1, 6R "Content of the dossier for CEP applications for chemical purity and microbiological quality of substances for pharmaceutical use" was published on the EDQM (European Directorate for the Quality of Medicines & HealthCare) website for comments. Comments and remarks on this draft can be submitted until 15 September 2023. Following the consultation period, the final document will be published on the EDQM website.
This draft is intended to provide guidance for applicants for a CEP (Certificate of Suitability). It applies to all substances listed in the European Pharmacopoeia for which the certification procedure is relevant. These are mainly active substances, but excipients described in the monographs may also be included. However, the requirements for excipients may differ from the requirements for active substances.
The draft for comment explains that a new CEP application should contain three modules.
The facts to be included in modules 1-3 are listed and explained in detail in the policy document. In principle, the structure should be as follows:
- Module 1: Cover Letter and Complete Application
- Module 2: Quality Overall Summary
- Module 3: Structure according to the CTD, i.e. analogous to ICH M4.
Related GMP News
16.04.2025EMA: Revised IRIS Documents
09.04.2025Centralised Procedures: Q&As Updated
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications